Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.
about
Second and third line treatment options for Helicobacter pylori eradicationTreatment of Helicobacter pylori infection: Where are we now?Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensusTreatment of Helicobacter pylori infection: Past, present and futureEfficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers.Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.Current recommendations for Helicobacter pylori therapies in a world of evolving resistance.Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease.Treatment of Helicobacter pylori infection 2013.Fluoroquinolone-based protocols for eradication of Helicobacter pyloriTreatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori.Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection.Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled TrSecond-line rescue treatment of infection: Where are we now?
P2860
Q26829666-7B948601-9AA0-4011-9F54-0DDC39C4DBB0Q30251567-F1060617-D349-47D6-B5F7-193C7DF92897Q33698340-CC54D643-DB4E-4987-9F28-1D494B054047Q34067951-DA9B751A-CD9F-4511-973D-BADD091D6882Q34508830-E2F401DF-C3CC-4E29-8F80-FD57503183FFQ35666640-C104BABB-ADFC-4B55-9A6E-ACACE4E974D9Q36086382-D011568C-AAE0-4316-8E96-7C43B5924EABQ37591509-2D6E8D92-94DD-4537-B067-038838BCE6AAQ37696038-9A2597AE-F061-4D37-977C-38E5B2ADB687Q38134877-D536C00A-5A42-4A0E-8E37-3D23948CF428Q38235943-552E18CC-246D-4144-BBAB-12A3E4F9182CQ38238745-9C9BF2DB-88C4-4D49-885E-C534FBEA9F58Q38496942-91F25749-CF8E-4876-9158-8263EC4AC7C1Q39135143-3A006322-6DC2-4715-A9E3-04F93B7D9E42Q40129982-50B65F06-3340-48D3-B9C5-5F133956B37EQ58602176-E71EDF44-613F-4924-BEB3-8D46CF3BE1D0
P2860
Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Levofloxacin/amoxicillin-based ...... ri eradication in second-line.
@ast
Levofloxacin/amoxicillin-based ...... ri eradication in second-line.
@en
type
label
Levofloxacin/amoxicillin-based ...... ri eradication in second-line.
@ast
Levofloxacin/amoxicillin-based ...... ri eradication in second-line.
@en
prefLabel
Levofloxacin/amoxicillin-based ...... ri eradication in second-line.
@ast
Levofloxacin/amoxicillin-based ...... ri eradication in second-line.
@en
P2093
P2860
P356
P1476
Levofloxacin/amoxicillin-based ...... ri eradication in second-line.
@en
P2093
Antonino De Lorenzo
Antonio Gasbarrini
Fabio Grizzi
Laura Di Renzo
Lucia Fini
Sara McCartney
Simona Di Caro
Stuart Bloom
Yayha Daoud
P2860
P304
P356
10.3748/WJG.V18.I40.5669
P407
P577
2012-10-01T00:00:00Z